The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness
The Journal of Infectious Diseases · 16.11.2026 · 234 (5) · e1083-e1094
DOI: 10.1093/infdis/jiag334 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 10.07.2026. Verfasst von Carlie N Skellington und 17 weiteren Autor:innen. Beteiligte Einrichtung: Madigan Army Medical Center, Joint Base Lewis-McChord, Washington, USA. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Analgesics, Vaccine Efficacy. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Infectious Disease Clinical Research Program, Department of War, Uniformed Services University of the Health Sciences.
Abstract (Originalsprache)
Background
Analgesic medications are sometimes taken prior to vaccination to prevent local and systemic adverse reactions. Although studies have examined the association between postvaccination analgesic use and immunogenicity, few have evaluated the effects of prevaccination analgesic use. This analysis assessed antibody response, influenza-like illness (ILI), and influenza infection among adults with and without analgesic use before influenza vaccination.
Methods
The Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED) study was an open-label, randomized trial evaluating the effectiveness of FDA-licensed influenza vaccines during 4 influenza seasons in adult military healthcare beneficiaries. PAIVED participants with data on analgesic use within 24 hours before vaccination were included in this analysis if they either provided prevaccination and postvaccination venous blood samples or participated in weekly ILI surveillance.
Results
Among 684 PAIVED participants with prevaccination and postvaccination antibody titers, 10.4% (n = 71) reported analgesic use before influenza vaccination. Multivariable analyses showed no association between analgesic use and geometric mean titer fold change. There was a modest association between acetaminophen use and increased seroconversion to influenza A/H3N2 compared with no analgesic use (aIRR = 1.37; P = .022); however, this association was not significant in sensitivity analyses adjusting for multiple comparisons. Among 10 723 PAIVED participants with ILI surveillance data, 10.6% (n = 1140) reported prevaccination analgesic use. Multivariable analyses revealed no association between analgesic use and incidence of ILI or odds of influenza infection.
Conclusions
These findings suggest acetaminophen and/or nonsteroidal anti-inflammatory analgesic use within 24 hours before influenza vaccination does not reduce vaccine immunogenicity or effectiveness in adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Madigan Army Medical Center, Joint Base Lewis-McChord, Washington, USA.
- Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, USA.
- Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
- Naval Medical Center Portsmouth, Portsmouth, Virginia, USA.
- Brooke Army Medical Center, San Antonio, Texas, USA.
ORCID-Profile: Carlie N Skellington, Kat Schmidt, Tahaniyat Lalani, Adam Saperstein, Alan Williams, Derek Larson, Bruce McClenathan, Laurie A Housel, Srihari Seshadri, Drake H Tilley
Förderung
- Infectious Disease Clinical Research Program
- Department of War
- Uniformed Services University of the Health Sciences
- Henry M. Jackson Foundation
- Advancement of Military Medicine, Inc.
- Defense Health
- U.S. Department of War
- Defense Health Agency Immunization Healthcare Division
Zitieren
APA
Skellington, C. N., Schmidt, K., Schofield, C., Ganesan, A., Lalani, T., Mende, K., Saperstein, A., Williams, A., Larson, D., McClenathan, B., Housel, L. A., Seshadri, S., Fries, A. C., Tilley, D. H., Pollett, S. D., Burgess, T. H., Richard, S. A., & Colombo, R. E. (2026). The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness. The Journal of Infectious Diseases, 234(5), e1083-e1094. https://doi.org/10.1093/infdis/jiag334
Vancouver
Skellington CN, Schmidt K, Schofield C, Ganesan A, Lalani T, Mende K, et al. The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness. The Journal of Infectious Diseases. 2026;234(5):e1083-e1094. doi:10.1093/infdis/jiag334
BibTeX
@article{Skellington2026,
author = {Skellington, Carlie N and Schmidt, Kat and Schofield, Christina and Ganesan, Anuradha and Lalani, Tahaniyat and Mende, Katrin and Saperstein, Adam and Williams, Alan and Larson, Derek and McClenathan, Bruce and Housel, Laurie A and Seshadri, Srihari and Fries, Anthony C and Tilley, Drake H and Pollett, Simon D and Burgess, Timothy H and Richard, Stephanie A and Colombo, Rhonda E},
title = {The Effect of Prevaccination Analgesics on Influenza Vaccine Immunogenicity and Effectiveness},
journal = {The Journal of Infectious Diseases},
year = {2026},
volume = {234},
number = {5},
pages = {e1083--e1094},
doi = {10.1093/infdis/jiag334}
}
EUVIMED